Ocular Toxicity With New Drugs for Gynecologic Cancers
Antibody-drug conjugates are a promising new option for gynecologic cancers, but they have a variety of ocular or vision-related adverse events that need to be appropriately monitored and managed.
Medscape Medical News
source https://www.medscape.com/viewarticle/990372?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/990372?src=rss
Comments
Post a Comment